GI CONNECT has summarised the highlights of the ASCO GI 2015 meeting in San Francisco for you.
Cancers of the Upper GI Tract by Dr Stintzing
GI CONNECT has summarised the highlights of the ASCO GI 2015 meeting in San Francisco for you.
Cancers of the Upper GI Tract by Dr Stintzing
Sebastian Stintzing (M.D.), Professor of Medicine, is Head of the Department of Hematology, Oncology and Cancer Immunology (CCM), Charité - Universitaetsmedizin Berlin. His research focuses on the treatment of GI cancer with a special focus on colorectal cancer. From 2012 to 2014, he was a research fellow at the Sharon Carpenter Laboratory at the University of Southern California Norris Comprehensive Cancer Center, Los Angeles, U.S.A. He coordinated the translational part and assisted the clinical study conduct of several studies and earned his Postdoctoral Lecture Qualification with a thesis on prognostic and predictive factors in the treatment of metastatic colorectal cancer. In 2012, he received the prestigious Research Fellowship Award from the German Cancer Aid in Germany. Prof. Stintzing is member of national and international cancer associations, member of the German S3 Guideline committee for colorectal cancer, and member of the steering committee of the working group Colorectal Carcinoma of the German AIO.
AMGEN, AstraZeneca, Bayer, BMS, CV6, Eisai, Isofol, Lilly, Merck KGaA, MSD, Pierre Fabre, Roche, Sanofi, Taiho, Takeda
Medical experts share their insights on testing and treatment
Medical experts discuss safety and efficacy of IO and IO combinations, clinical trial data, and best practice
Expert opinion on the clinical application of artificial intelligence (AI)
Medical experts share insights and review key clinical trials
Findings from a global survey presented in a poster at ESMO 2024